[an error occurred while processing this directive]
临床研究

使用生物电阻抗技术辅助确定腹膜透析患者目标体质量的随机对照研究

  • 武蓓 ,
  • 王梅 ,
  • 赵慧萍 ,
  • 左力 ,
  • 乔婕 ,
  • 芦丽霞 ,
  • 邵琳 ,
  • 门春翠 ,
  • 何玉婷
展开
  • 1. 北京大学人民医院肾内科

收稿日期: 2019-12-02

  修回日期: 2019-12-30

  网络出版日期: 2020-03-12

基金资助

2015 年度北京大学人民医院研究与发展基金(课题编号:RDC2015-31)

Determination of target body weight of peritoneal dialysis patients by bioimpedance: a randomized controlled clinical study

  • WU Bei ,
  • WANG Mei ,
  • ZHAO Hui-Ping ,
  • ZUO Li ,
  • QIAO Jie ,
  • LU Li-Xia ,
  • SHAO Lin ,
  • MEN Chun-Cui ,
  • HE Yu-Ting
Expand
  • 1 Department of Nephrology, Peking University People’s Hospital, Beijing 100044, China

Received date: 2019-12-02

  Revised date: 2019-12-30

  Online published: 2020-03-12

摘要

【摘要】目的验证以生物电阻抗分析辅助确定腹膜透析患者目标体质量的临床有效性和安全性。方法75 名腹膜透析患者随机分为传统方法评价组和机体成分测定(body composition monitor,BCM)评价组。BCM 评价组用实测体质量-过多水(over hydration,OH)+2kg 作为目标体质量,指导患者容量管理。6 个月后,比较2 组试验前后容量相关指标的变化差异。结果BCM 测量的OH 值与传统容量评价指标水肿程度积分(r=0.366,P=0.001)、日降压药剂量(defined daily doses, DDDs)(r=0.440,P<0.001)、收缩压(r=0.494,P<0.001)、舒张压(r=0.414,P<0.001)、左心室舒张末内径(r=0.591,P<0.001)、脑钠肽(natriuretic peptide,BNP)(r=0.615,P<0.001)呈正相关,与白蛋白(r=-0.354,P =0.002)呈负相关。经BCM 指导设定目标体质量治疗6 个月后,BCM 组体质量[(60.4 ± 10.6)比(59.6±10.2)kg,t=2.988,P=0.005]、收缩压[(136.5±23.9)比(126.9±20.3)mmHg,t=2.238,P=0.033]、中度以上水肿患者比例(46.9%比37.5%,χ2=15.469,P<0.001)均较试验前明显下降。对照组实验前后上述指标无明显变化。结论以BCM 协助确定患者目标体质量的方法可有效用于腹膜透析患者的容量管理。

本文引用格式

武蓓 , 王梅 , 赵慧萍 , 左力 , 乔婕 , 芦丽霞 , 邵琳 , 门春翠 , 何玉婷 . 使用生物电阻抗技术辅助确定腹膜透析患者目标体质量的随机对照研究[J]. 中国血液净化, 2020 , 19(03) : 165 -169 . DOI: 10.3969/j.issn.1671-4091.2020.03.006

Abstract

【Abstract】Objective To verify the clinical effectiveness and safety of using bioimpedance to determine the target body weight of peritoneal dialysis (PD) patients. Methods A total of 75 PD patients were randomly divided into traditional method group and body composition monitor (BCM) group. BCM group used the formula: target body weight = measured body weight - over hydration (OH) + 2 kg, to guide patient volume management. After 6 months, changes of blood pressure, edema degree and brain natriuretic peptide (BNP) were compared between the two groups. Results The OH value by BCM was positively correlated with edema degree (r=0.366, P=0.001), defined daily doses (DDDs) of blood pressure medications (r=0.440, P<0.001), systolic pressure (r=0.494, P<0.001), diastolic pressure (r=0.414, P<0.001), left ventricular end diastolic dimension (r=0.591, P<0.001) and BNP (r=0.615, P<0.001), and was negatively correlated with albumin (r=-0.354, P=0.002). In BCM group after 6 months, body weight (60.4±10.6 vs. 59.6±10.2; t=2.988, P=0.005), systolic blood pressure (136.5±23.9 vs. 126.9±20.3; t=2.238, P= 0.033) and the patients with moderate or higher than moderate edema (46.9% vs. 37.5%; χ2=15.469, P<0.001) decreased; these changes were not observed in control group. Conclusion BCM can be used to help determine target body weight of PD patients.

参考文献

1.Yeates K , Zhu N , Vonesh E , et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada[J]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, 27(9):3568-3575.
2.Van de Luijtgaarden M, Noordzij M, Wanner C, et al. Renal replacement therapy in Europe- a summary of the 2009 ERA-EDTA Registry Annual Report. Clin Kidney J (2012) 5: 109–119.
3.Ates K,Nergizoglu G,Keven K,et a1.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney lnt,2001,60:767—776.
4.Plum J,Schoenieke G,Kleophas W ,et a1.Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.Nephrol Dial Transplant,2001,16:2378—2385.
5.Papakrivopoulou E , Booth J , Pinney J , et al. Comparison of Volume Status in Asymptomatic Haemodialysis and Peritoneal Dialysis Outpatients[J]. Nephron Extra, 2012, 2(1):48-54.
6.Charra B , Laurent G , Chazot C , et al. Clinical assessment of dry weight[J]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, 11 Suppl 2(supp2):16.
7.Lopot F , B Nejedly, H Novotná, et al. Age-related extracellular to total body water volume ratio (ECV/TBW)--can it be used for "dry weight" determination in dialysis patients? Application of multifrequency bioimpedance measurement.[J]. International Journal of Artificial Organs, 2002, 25(8):762-769.
8.Chamney P W , Matthias Kr?mer, Rode C , et al. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance[J]. Kidney International, 2002, 61(6):2250-2258.
Graham Scotland, Moira Cruickshank, Elisabet Jacobsen, et al.Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation.Health Technol Assess. 2018 ; 22(1): 1–138.9.
Wim V B , Williams J D , Covic A C , et al. Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort[J]. PLoS ONE, 2011, 6(2):e17148-.10.
11.Guo Q, Yi C, Li J, et al. Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One. 2013;8(1):e53294.
12.Kwan C H , Szeto C C , Chow K M , et al. Bioimpedance Spectroscopy for the Detection of Fluid Overload in Chinese Peritoneal Dialysis Patients[J]. Peritoneal Dialysis International, 2014, 34(4):409-416.
13.江岚, 刘泉颖, 程李涛, et al. 新容量超负荷指标overhydration在腹膜透析患者中的临床价值[J]. 中华肾脏病杂志, 2010, 26(2):86-90.
14.徐耀文, 高琛妮, 徐天, et al. 多频生物电阻抗分析法评估腹膜透析患者左心室肥厚容量负荷状态及其相关因素[J]. 上海医学, 2016(5):296-300.
15.赵班, 何雪梅, 李天慧, et al. 多频生物电阻抗法在腹膜透析患者容量评估中的价值[J]. 中国血液净化, 2016, 15(10):550-553.
文章导航

/

[an error occurred while processing this directive]